Galaxy Medicare Ltd (GML) — shareholding pattern, promoter holding, financials and share price
About Galaxy Medicare Ltd (GML)
Galaxy Medicare Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as GML and on the BSE under scrip code 94616. Its ISIN is INE09A801015.
Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India. [1]
Listed peers in Medical Equipment & Supplies: Shree Pacetronix Ltd, KMS Medisurgi Ltd, Amkay Products Ltd, GKB Ophthalmics Ltd, Centenial Surgical Suture Ltd, Transpact Enterprises Ltd.
Valuation & Returns
10 Jul 2026At ₹18.8 a share on 10 Jul 2026, Galaxy Medicare Ltd (GML) was valued at a price-to-earnings ratio of 8.34x against an industry P/E of 44.11x and a price-to-book of 0.83x on a book value of ₹22.77 per share. Solomo computes return on equity of 8.47% and return on capital employed of 11.15% from filed results.
- P/E
- 8.34x
- Industry P/E
- 44.11x
- P/B
- 0.83x
- EPS (TTM)
- ₹2.84
- Book value / share
- ₹22.77
- ROE
- 8.47%
- ROCE
- 11.15%
- ROA
- 7.01%
- Debt / equity
- 0.1x
- Dividend yield
- 3.99%
- EBITDA margin
- 13.85%
- 52-week range
- ₹15.15 – ₹54
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Galaxy Medicare Ltd (GML) reported revenue of ₹40 crore, net profit of ₹3.42 crore and earnings per share of ₹2.25. That compares with revenue of ₹38.86 crore and net profit of ₹3.37 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹21.27 crore and net profit ₹1.4 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 29.88 | 30.94 | 35.84 | 38.86 | 40 |
| Net profit (₹ cr) | -0.21 | 1.57 | 3.71 | 3.37 | 3.42 |
| EPS (₹) | - | 5.16 | 3.13 | 2.84 | 2.25 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 9.48% | 8.44% |
| Profit growth | - | -9.16% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 72.98% of Galaxy Medicare Ltd (GML). Market capitalisation was ₹29 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2025.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 72.98% | - | - | - | - |
| Sep 2025 | 72.43% | - | - | - | - |